78 related articles for article (PubMed ID: 28844347)
1. Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].
Eggink FA; Mom CH; Bouwman K; Boll D; Becker JH; Creutzberg CL; Niemeijer GC; van Driel WJ; Reyners AK; van der Zee AG; Bremer GL; Ezendam NP; Kruitwagen RF; Pijnenborg JM; Hollema H; Nijman HW; van der Aa MA
Eur J Cancer; 2017 Oct; 84():370. PubMed ID: 28844347
[No Abstract] [Full Text] [Related]
2. Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.
Eggink FA; Mom CH; Bouwman K; Boll D; Becker JH; Creutzberg CL; Niemeijer GC; van Driel WJ; Reyners AK; van der Zee AG; Bremer GL; Ezendam NP; Kruitwagen RF; Pijnenborg JM; Hollema H; Nijman HW; van der Aa MA
Eur J Cancer; 2017 Jun; 78():82-90. PubMed ID: 28415003
[TBL] [Abstract][Full Text] [Related]
3. A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis.
Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Engh ME; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Salvesen HB
Eur J Cancer; 2013 Feb; 49(3):625-32. PubMed ID: 23036850
[TBL] [Abstract][Full Text] [Related]
4. DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer.
Di Cello A; Di Sanzo M; Perrone FM; Santamaria G; Rania E; Angotti E; Venturella R; Mancuso S; Zullo F; Cuda G; Costanzo F
Tumour Biol; 2017 Jun; 39(6):1010428317705746. PubMed ID: 28618925
[TBL] [Abstract][Full Text] [Related]
5. Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.
d'Engremont C; Vernerey D; Pointet AL; Simone G; Fein F; Heyd B; Koch S; Vuitton L; Kim S; Jary M; Lamfichek N; Turco C; Lakkis Z; Berger A; Bonnetain F; Taieb J; Bachellier P; Borg C
BMC Cancer; 2016 Oct; 16(1):823. PubMed ID: 27782813
[TBL] [Abstract][Full Text] [Related]
6. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum to "Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer" [Eur J Cancer 40 (18) (2004) 2717-2725].
Martin TA; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2018 Jan; 88():115-116. PubMed ID: 29174182
[No Abstract] [Full Text] [Related]
8. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "DHEA improves the antioxidant capacity of endometrial stromal cells and improves endometrium receptivity via androgen receptor" [Eur. J. Obstet. Gynecol. Reprod. Biol. 198 (2016) 120-126].
Qin J; Qin A; Jin Y; Xie W; Fan L; Jiang L; Mo F
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():132. PubMed ID: 27118103
[No Abstract] [Full Text] [Related]
10. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
[TBL] [Abstract][Full Text] [Related]
11. Perioperative outcomes of total laparoendoscopic single-site hysterectomy versus total robotic hysterectomy in endometrial cancer patients: a multicentre study.
Fagotti A; Gagliardi ML; Fanfani F; Salerno MG; Ercoli A; D'Asta M; Tortorella L; Turco LC; Escobar P; Scambia G
Gynecol Oncol; 2012 Jun; 125(3):552-5. PubMed ID: 22391483
[TBL] [Abstract][Full Text] [Related]
12. Preoperative diagnosis of tumor grade and type in endometrial cancer by pipelle sampling and hysteroscopy: Results of a French study.
Phelippeau J; Canlorbe G; Bendifallah S; Naoura I; Lefevre M; Ballester M; Daraï E
Surg Oncol; 2016 Dec; 25(4):370-377. PubMed ID: 27916168
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118].
Andersson TM; Weiderpass E; Engholm G; Lund AQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
Eur J Cancer; 2017 Dec; 87():219-220. PubMed ID: 29029964
[No Abstract] [Full Text] [Related]
14. Corrigendum to "2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer" [Eur J Cancer 63 (August 2016) 11-24].
Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
Eur J Cancer; 2016 Nov; 68():208-209. PubMed ID: 27717654
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].
Lambrechts S; Smeets D; Moisse M; Braicu EI; Vanderstichele A; Zhao H; Van Nieuwenhuysen E; Berns E; Sehouli J; Zeillinger R; Darb-Esfahani S; Castillo-Tong DC; Lambrechts D; Vergote I
Eur J Cancer; 2016 Jun; 60():226. PubMed ID: 27106403
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671].
Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
Eur J Surg Oncol; 2017 Jul; 43(7):1380-1381. PubMed ID: 28526188
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116].
Puliti D; Bucchi L; Mancini S; Paci E; Baracco S; Campari C; Canuti D; Cirilli C; Collina N; Conti GM; Di Felice E; Falcini F; Michiara M; Negri R; Ravaioli A; Sassoli De' Bianchi P; Serafini M; Zorzi M; Caldarella A; Cataliotti L; Zappa M;
Eur J Cancer; 2017 Nov; 85():160. PubMed ID: 28870467
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours" [Eur J Cancer 69 (2016) 151-157].
Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
Eur J Cancer; 2017 Apr; 75():333. PubMed ID: 28283351
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
[No Abstract] [Full Text] [Related]
20. Magnetic resonance imaging in pre-operative staging of endometrial cancer.
Shrivastava S; Barmon D; Kataki AC; Deka P; Sharma JD; Choudhary BK; Baruah U
Indian J Cancer; 2016; 53(1):181-5. PubMed ID: 27146774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
